Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical

Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang, Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang

Abstract

Background: Coronavirus disease 2019 (COVID-19) virus is still spreading, finding out the initial hits of viral infection is important to minimize the mild/moderate population, prevent disease aggravation and organs dysfunction. Objective: We investigated COVID-19 patients with different serum calcium levels.

Design: We checked the serum calcium level of the patients based on days after symptom onset as well as the severity of COVID-19. We also checkeed multi-organ injuries and immune cytokines level in their blood.

Results: Both mild/moderate and severe critical cases we observed showed low calcium level in the early stage of viral infection, while the severe/critical cases showed significant lower calcium level than mild/moderate cases in the early stage. We also found that low calcium level related to severe/critical multi-organ injuries especially in the mild/moderate population. Proinflammatory cytokine IL-6 also correlated to calcium change in both mild/moderate and severe/critical cases.

Conclusions: Our finding indicates that calcium balance is a primal hit of COVID-19 and a biomarker of clinical severity at the beginning of symptom onset. Calcium is closely associated with virus-associated multiple organ injuryes and the increase of inflammatory cytokines. Our results provide a new, important indicator of COVID-19 patients from mild/moderate to severe/critical: serum calcium.

Keywords: COVID-19; Multi-organ injury; Pro-inflammatory cytokine; Serum calcium.

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Copyright 2020 The Author(s).

Figures

Figure 1. The association between serum calcium…
Figure 1. The association between serum calcium in COVID-19 patients with disease severity, age and days after symptom onset
Independent group t test was used to compare the means for continuous variables. A P-value of less than 0.05 was considered to be statistically significant with a two-sided alternative. (A–D) Various kinds of serum ions (a. potassium ion; b. sodium ion; c. chloride ion; d. calcium ion) concentrations in COVID-19 patients vary with the number of days after symptom onset. (E) Calcium level in COVID-19 patients grouped by severity of illness. (F) Low calcium and normal patients age distribution (normal (serum calcium concentration ≥ 2.2 mmol/l), low (serum calcium concentration < 2.2 mmol/l). (G) Calcium level in mild/moderate and severe/critical COVID-19 patients vary with the number of days after symptom onset. (H) The age distribution of mild/moderate and severe/critical cases in different timing after symptom onset was checked.
Figure 2. The calcium level in the…
Figure 2. The calcium level in the patients with or without coexisting disorder
(A) The calcium level in the patients with or without coexisting disorder. (B,C) Patients were divided into five groups (no underlying diseases, hypertension+others, hypertension+diabetes, diabetes+others, others) and measured the calcium level (B) and the age distribution (C) separately for each group. (D,E) When we exclude the patients with hypertension plus with diabetes, the calcium level in mild/moderate and severe/critical COVID-19 patients vary with the number of days after symptom onset (D) and the age distribution of mild/moderate and severe/critical cases in different timing after symptom onset was checked (E).

References

    1. Guan W.J., Ni Z.Y., Hu Y. et al. . (2020) Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 10.1056/NEJMoa2002032
    1. Huang C., Wang Y., Li X. et al. . (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 10.1016/S0140-6736(20)30183-5
    1. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report 124.
    1. Wu Z. and McGoogan J.M. (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239–1242 10.1001/jama.2020.2648
    1. Wang T. et al. . (2020) Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 395, e52 10.1016/S0140-6736(20)30558-4
    1. Desai T.K., Carlson R.W. and Geheb M.A. (1988) Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am. J. Med. 84, 209–214 10.1016/0002-9343(88)90415-9
    1. Lippi G., South A.M. and Henry B.M. (2020) Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann. Clin. Biochem. 57, 262–265 10.1177/0004563220922255
    1. Cappellini F., Brivio R., Casati M., Cavallero A., Contro E. and Brambilla P. (2020) Low levels of total and ionized calcium in blood of COVID-19 patients. Clin. Chem. Lab. Med. 58, e171–e173, 10.1515/cclm-2020-0611
    1. Chen D., Li X., Song Q., Hu C., Su F., Dai J. et al. . (2020) Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Netw. Open 3, e2011122 10.1001/jamanetworkopen.2020.11122
    1. Wu C.I., Postema P.G., Arbelo E. et al. . (2020) SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. Heart Rhythm 17, 1456–1462 10.1016/j.hrthm.2020.03.024
    1. Corman V.M., Landt O., Kaiser M. et al. . (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surv. 25, 2000045.published correction appears in Euro Surveill. 10.2807/1560-7917.ES.2020.25.3.2000045
    1. China NHCo New coronavirus pneumonia prevention and control program (7th). (2020)
    1. Wu Z. and McGoogan J.M. (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239–1242 10.1001/jama.2020.2648
    1. Meredith W., Jennifer C.F., Jocelyn K. and Catherine M.. How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes. Biol. Coronavirus 10.1126/science.abc3208
    1. Chen N. et al. . (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 10.1016/S0140-6736(20)30211-7
    1. Shi S., Qin M., Shen B. et al. . (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5, 802–810 10.1001/jamacardio.2020.0950
    1. Zhen L., Ming W., Jie G. et al. . (2020) Caution on kidney dysfunctions of 2019-nCoV patients. 10.1101/2020.02.08.20021212v1
    1. Xiaoqiang C., Longfei H., Yan Z. et al. .. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 10.1101/2020.02.03.931766 2020.02.03.931766
    1. Vandenbroucke A., Luyten F.P., Flamaing J. and Gielen E. (2017) Pharmacological treatment of osteoporosis in the oldest old. Clin. Interv. Aging 12, 1065–1077, 10.2147/CIA.S131023
    1. Chang-Graham A.L., Perry J.L., Strtak A.C. et al. . (2019) Rotavirus calcium dysregulation manifests as dynamic calcium signaling in the cytoplasm and endoplasmic reticulum. Sci. Rep. 9, 10822, 10.1038/s41598-019-46856-8
    1. Hyser J.M. and Estes M.K. (2015) Pathophysiological consequences of calcium-conducting viroporins. Annu. Rev. Virol. 2, 473–496 10.1146/annurev-virology-100114-054846
    1. Liu J., Li S., Liu J. et al. . (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. Ebiomedicine 55, 102763 10.1016/j.ebiom.2020.102763
    1. Zhou F., Yu T., Du R. et al. . (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020;395(10229):1038]. Lancet 395, 1054–1062
    1. Nieto-Torres J.L., DeDiego M.L., Verdiá-Báguena C. et al. . (2014) Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 10, e1004077, 10.1371/journal.ppat.1004077
    1. Nieto-Torres J.L., Verdiá-Báguena C., Jimenez-Guardeño J.M. et al. . (2015) Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485, 330–339 10.1016/j.virol.2015.08.010
    1. Hendy G.N. and Canaff L. (2016) Calcium-sensing receptor gene: regulation of expression. Front. Physiol. 7, 394, 10.3389/fphys.2016.00394
    1. Peacock M. (2010) Calcium metabolism in health and disease. Clin. J. Am. Soc. Nephrol. 5, S23–S30 10.2215/CJN.05910809
    1. Wang B., Li D., Gong Y., Ying B. and Cheng B. (2019) Association of serum total and ionized calcium with all-cause mortality incritically ill patients with acute kidney injury. Clin. Chim. Acta 494, 94–99 10.1016/j.cca.2019.03.1616
    1. Jafari M., Di Napoli M., Datta Y.H., Bershad E.M. and Divani A.A. (2019) The role of serum calcium level in intracerebral hemorrhage hematoma expansion: is there any? Neurocrit. Care 31, 188–195 10.1007/s12028-018-0564-2
    1. Lauder S.N., Allen-Redpath K., Slatter D.A. et al. . (2017) Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis. Sci. Signal. 10, eaan2787, 10.1126/scisignal.aan2787
    1. Kuebler W.M., Jordt S.E. and Liedtke W.B. (2020) Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach. Am. J. Physiol. Lung Cell Mol. Physiol. 318, L1239–L1243 10.1152/ajplung.00161.2020
    1. Dibaba D.T., Xun P., Fly A.D. et al. . (2019) Calcium intake and serum calcium level in relation to the risk of ischemic stroke: findings from the REGARDS Study. J. Stroke 21, 312–323 10.5853/jos.2019.00542

Source: PubMed

3
订阅